甲基化物和莫达菲尼尔减轻了斯科波胺诱导的行为变化
Nausheen Alam1, Safia Abdul Quddoos1, Humera Khatoon2
1Department of Pharmacology, Faculty of Pharmacy, Federal Urdu University, Block 9, Gulshan-e-Iqbal, Karachi 75300, Pakistan.
ACS pharmacology & translational science
|July 17, 2025
概括
这项研究表明,精神兴奋剂modafinil和methylphenidate可以改善痴呆症的老鼠模型中的认知和运动缺陷. 这两种药物都提供治疗效益,甲基酸在认知增强方面表现出色.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 痴呆症与胆固醇神经元退化有关,导致认知和运动障碍.
- 多巴胺作用机制对于调节胆性传播至关重要,这表明精神兴奋剂的作用.
- 在老鼠中,斯科波胺诱导的痴呆症模仿了人类认知和运动缺陷的关键方面.
研究的目的:
- 研究摩达菲尼尔和甲基酸在斯科波拉胺诱导痴呆症的小鼠模型中的治疗潜力.
- 评估这些精神兴奋剂对运动技能,认知功能和运动活动的影响.
- 为了比较modafinil和methylphenidate在改善痴呆相关缺陷方面的疗效.
主要方法:
- 给老鼠注射了斯科波拉来诱导类似痴呆症的症状.
- 治疗剂量莫达菲尼尔 (75毫克/公斤/天) 和甲基 (10毫克/公斤/天) 被口服.
- 评估了运动技能 (静止棒测试),认知功能 (迷宫,被动回避测试) 和运动活动.
主要成果:
- 斯科波胺的使用导致运动能力减弱,运动技能受损和记忆功能障碍.
- 莫达菲尼尔和甲基酸盐都显著改善了运动协调和认知功能.
- 甲基化物显示出优异的认知改善,而modafinil显示出运动活动的更大增加;整体疗效是可比的.
- 在第二周的modafinil治疗中观察到行为敏感性.
结论:
- 莫达菲尼尔和甲基酸作为与痴呆症相关的认知和运动缺陷的潜在治疗方法具有前景.
- 这些精神兴奋剂可能在开发神经退行性疾病治疗中发挥作用.
- 需要进一步的研究,以了解莫达菲尼尔诱导的运动运动敏感性的影响,并考虑长期使用的风险.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
212
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
212
Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
335
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
335
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
628
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
628


